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INTRODUCTION  
Microbial infections remain the major cause of death 
over the world. Emergence of multi-drug resistant to 
different infectious organisms like M. tuberculosis 
made the condition most alarming.[1-2] Tuberculosis, 
MTB, or TB is a deadly infectious disease caused by 
various strains of mycobacteria; usually Mycobac-
tеrium tuberculosis. According to World Health Organ-
ization (WHO) TB is a global pandemic, which has be-
come an important world-wide public health menace 
with one-third of the world’s population infected by 
the TB bacillus. Most infections do not havе symptoms, 
known as latеnt tubеrculosis and about onе in tеn 
latеnt infеctions еvеntually progrеssеs to activе disеasе 
which, if lеft untrеatеd, kills morе than 50% of thosе 
so infеctеd. Pеoplе with wеak immunе systеms (thosе 
with HIV/AIDS, thosе rеcеiving immunosupprеssivе 
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drugs and chеmothеrapy) arе at a grеatеr risk for 
dеvеloping TB disеasе. Thеrе is currеntly a growing 
concеrn about thе progrеss and sprеad of multidrug 
and еxtеnsivеly drug resistant tuberculosis (MDR/XDR
-TB), which has thе potеntial to paralyzе TB carе 
schеmеs. Thе focal thеmе of this thеsis is thе 
еxploration of nеw stratеgiеs in thе fiеld of modеrn 
drug discovеry for thе dеvеlopmеnt of nеw drugs, 
which are capablе of ovеrcoming MDR/XDR-TB. The 
present work was aimed to synthesized new compound 
and evaluate it for antituberculer activity. Therefore, 
there is an urgent demand for a new class of antimicro-
bial agent with a different mode of action and it led 
medicinal chemists to explore a wide variety of chemi-
cal structures. 
Quinoline was first isolated from coal tar in 1834, it was 
also recognized as pyrolytic degradation product of 
cinchonamine, an alkaloid closely related to quinine[3-
6]. The name quinoline was derived from quina, a 
Spanish version of a local South American name for the 
bark of quinine-containing cinchona Species. Several 
Synthetic anti-malarial drugs are based on the quino-
line nucleus, Chloroquine is an example. Several antibi-
otics like fluro-quinolones now in clinical use were 4-
quinolone-based antibiotics.[7-10] Quinoline is a color-
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less liquid of bp. 2370C. It turns yellow on standing and 
has pyridine like smell.Miscible with most organic sol-
vents and dissolves in water to about 0.7 % at room 
temperature. Slightly weaker base (pKa= 4.94) than 
pyridine (pKa= 5.2). It reacts with acid to yield salts 
which are sparing soluble in water[11-12]. 
Compounds containing quinolones exhibiting variety of 
pharmacological and biological activities[13-25]. 
Experimental 
General: The nucleus and its derivatives were analyzed 
by different ways. The melting points were recorded on 
electrothermal apparatus and are uncorrected.(IR) 
spectra were determined on Bruker IFS-66 FTIR (Bruker 
Bioscience, USA) using KBr pallets and wave number (í) 
was reported in cm-1.  1H NMR spectra on a Bruker 
Avance 300 MHz instrument using DMSO as solvent 
using TMS as internal standard; the chemical shifts (δ) 
were reported in ppm with coupling constants (J) are 
given in Hz. Signal multiplicities were represented by s 
(singlet), d (doublet), t (triplet), ds (double singlet), dd 
(double doublet), m (multiplet) and bs (broad singlet. 
Elemental analysis was performed on a Hera- cus CHN-
Rapid Analyzer. Analysis indicated by the symbols of 
the elements of functions was within ±0.4% of the the-
oretical values. The purity of the compounds was 
checked on silica gel coated Al plates (Merck). 
Synthesis of 2-methyl-7-substituted-4-quinolone  
 A mixture of (0.01 mol) substituted anilines and (0.01 
mol) ethyl acetoacetate was stirred, was heated  on 
oil bath at 1800C for two hours, The crude solid was 
filtered, dried and recrystallized from ethanol . 
 2. Synthesis of 7-substituted-2-(3-chloro-2-oxopropyl) 
quinolin-4(1H)-one (II)  
An quantity of 0.01 moles of I was dissolved in 25 ml of 
glacial acetic acid. If did not dissolve completely, the 
mixture was slightly warmed. The solution was cooled 
in ice bath with stirring. To this chloroacetyl chloride 
(0.12 mole) solution added drop wise. To prevent the 
occurrence of vigorous reaction the temp was main-
tained at 0oC then reaction was heated for 30 mins 
after this cool the mixture and pour over crushed ice 
white product was separated by filtration. The product 
was washed with 50% aqueous acetic acid and finally 
with water. It was recrystallized.  
3. Synthesis of derivatives of substituted 4-quinolones 
III  
A mixture of 0.01 mole of each II were taken in  dry 250 
ml  round bottom flask separately to this distilled alco-
hol is added as solvent and to this different secondary 
amines were added  in 0.01 mole concentrations and 
refluxed for 2 hour after reflux add  reaction mixture to 
crushed ice precipitation formed is filtered and recrys-
tallized. 
Spectral Data 
A1- IR (KBr): 3487.07 (-N-H str), 3032.16  (Ar-H 
str), 2841 ( CH str), 1721 (-C=O str), 1685 (CO str am-
ide), 1160 (-C-N str), 801(-C-Clstr) NMR: d8.5-8.(0 1H, S-
NH), 7.91-7.87 (4H ,m-Quinolone), 7.37-6.97 4H,m -Ar-
CH 3.81-3.12 2H,d -CH2 
A2- IR (KBr): 3487.07 (-N-H str), 3135(Ar-H str), 
2561 ( CHstr), 1721 (-C=O str), 1685 (CO str amide), 
1353 (–SO2NH2 str), 1200 (-C-N str) 801(-C-Clstr)  
A3- IR (KBr): 3372 (-N-H str), 3032(Ar-H str), 
2850 ( CHstr), 1720 (-C=O str), 1685 (CO str amide), 
1200 (-C-N str) 780 (-C-Clstr)  
A4- IR (KBr):3420 (-OH str), 3380 (-N-H str), 
3020(Ar-H str), 2862 ( CHstr), 1700 (-C=O str), 1685 (CO 
str amide), 1230 (-C-N str) 759 (-C-Clstr)  
B1- IR (KBr):3367 (-NH str), 3021 (-Ar-H str), 
2848(-CH str), 1728 ( -C=O str), 1655 (CO str amide), 
1157 (-C-N str) 662 (-C-Br str)  
B2- IR (KBr):3367 (-NH str), 3021 (-Ar-H str), 
2848(-CH str), 1728 ( -C=O str), 1655 (CO str amide), 
1353 ((–SO2NH2 str))1157 (-C-N str) 662 (-C-Br str)  
B3- IR (KBr): 3372 (-N-H str), 3032(Ar-H str), 
2850 ( CHstr), 1720 (-C=O str), 1685 (CO str amide), 
1200 (-C-N str) 645 (-C-BR str)  
B4- IR (KBr):3420 (-OH str), 3370 (-N-H str), 
3020(Ar-H str), 2850 ( CHstr), 1690 (-C=O str), 1680 (CO 
str amide), 1230 (-C-N str) 650 (-C-Br str)  
Anti-tubercular activity: The compounds were tested 
in-vitro for their anti-tubercular activity against H37Rv 
Strain.  
Method: Alamar Blue Dye:  The anti-tubercular screen-
ing was carried out by Middle brook 7H9 agar medium 
against H37Rv Strain. Middle brook 7H9 agar medium 
was inoculated with Mycobacterium tuberculosis of 
H37Rv Strain. The inoculated bottles were incubated for 
37°C for 4 weeks. At the end of 4 weeks they were 
checked for growth.  
RESULT 
Scheme: (A1-A4, B1-B4) 
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Table 1. Derivative compounds 
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Comp. 
Code 
Mol. 
Formula 
Mol. 
Wt. 
m.p. 
° C 
Yield 
% 
Rf val-
ue 
Elemental analyses 
Calcd. (Found) 
C H N 
A1 C18H15ClN4O3 370.78 180-182 79.85 0.50 58.31 4.08  15.11 
A2 C18H16ClN4O4S 405.85 142-144 72.53 0.57 53.27 3.97 10.35 
A3 C17H13ClN4O3 356.76 130-132 69.52 0.53 57.23 3.67 15.70 
A4 C18H22ClN3O4 379.83 136-138 74.54 0.50 56.92  5.84  11.0  
B1 C18H15BrN4O3 415.24 110-112 75.34 0.61 52.06 3.64 13.49 
B2 C18H16BrN3OS 450.30 140-142 74.67 0.59 48.01 3.58 9.33 
B3 C17H13BrN4O3 401.21 112-114 72.23 0.65 50.89 3.27  13.9  
B4 C18H22BrN3O4 424.28 136-138 62.12 0.64 50.95 5.23 9.90 
Comp 
ID 
100 50 25 12.5 6.25 3.125 1.6 0.8 0.4 0.2 
                      
A1 S S S S S S S R R R 
A2 S S S S R R R R R R 
A3 S S S S S S S S R R 
A4 S S S R R R R R R R 
B1 S S S S S S S R R R 
B2 S S S S S R R R R R 
B3 S S S S S S S S S R 
B4 S S S S R R R R R R 
Strepto-
mycin 
S S S S S R R R R R 
Table 2.  Anti-tubercular activity of substituted 4-quinolones compounds  
Table 3. Analytical data of the compound  
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Figure 1. IR Spectra of A1 
Figure 2. NMR Spectra of A1 
DISCUSSION: 
In the present research work, we have synthesized 8 
new substituted 4-quinolones derivatives as explained 
in the scheme. The purity of the compounds was 
checked by TLC and melting point. Structures of these 
compounds were confirmed by IR, 1HNMR and ele-
mental analysis. The synthesized compounds were sub-
jected to anti tubercular activity by Alamar Blue Dye 
method against the standard streptomycin.  
Compound A1, A3, B1, B3 have shown promising an-
titubercular activity against streptomycin at concentra-
tion of 1.6 mcg/ml by interpreting data of MIC. With 
the suitable molecular modification and manipulation 
with possible SAR studies of these compounds, promis-
ing anti tubercular agents can be obtained. [26, 27]. 
CONCLUSION 
The substituted quinolones are synthesized by taking 
mixture of 7-substituted-2-(3-chloro-2-oxopropyl) quin-
olin-4(1H)-one and different secondary amines. It was 
found that Compound A1, A3, B1, B3, have shown promis-
ing anti tubercular activity whereas compound A2, 
A4,B2,B4 were showing moderate anti tubercular activi-
ty  against std. Streptomycin. 
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